ijms-logo

Journal Browser

Journal Browser

Basic and Translational Models of Cooperative Oncogenesis

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: closed (31 March 2020) | Viewed by 34180

Special Issue Editors


E-Mail Website
Guest Editor
Cell Polarity, Cell Signaling & Cancer Laboratory, Department of Biochemistry & Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia
Interests: cell polarity; cell signaling and cancer; model tumourigenesis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dipartimento di Medicina Clinica, Sanità Pubblica, Scienze della Vita e dell’Ambiente, Università Dell’Aquila, 67100 L’Aquila, Italy
Interests: cancer genetics; MYC-mediated cell competition; model tumourigenesis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Stem cells in tissue homeostasis and transformation Institute of Cancer Science, University of Glasgow, Glasgow, UK
Interests: stem cells; tumourigenesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer is a complex disease that develops through the acquisition of a number of genetic lesions and epigenetic changes, some of which may lead cells a step closer to malignancy. Tumour cells can accumulate hundreds of mutations, and aggressive cancers may be composed of a number of genetically heterogeneous clones, making their molecular traits difficult to decipher. It is thus mandatory to establish the contribution of the different genes and pathways that cooperate in providing the tumour cells with specific phenotypic traits. Both basic and translational cancer research have greatly benefited from the use of suitable cellular and animal models, which have helped to characterise the molecular basis of many cancer hallmarks. In recent years, elaborate cellular models have been conceived that enable the in vitro study of intricate relationships occurring between cancer cells, blood vessels, and other stromal components. Additionally, sophisticated in vivo models have provided substantial insights into how tumour cells evolve and interact with the surrounding tissue during cancer initiation and progression, including the mechanisms mediating the systemic effects of cancer. As the cellular and molecular mechanisms governing cancer growth have been shown to be highly conserved between humans, mice, fish, worms, and flies, we anticipate that other innovative experimental models will be developed and used in the future in order to address particular aspects of malignant transformation.

We invite investigators to contribute original research articles and review articles describing and discussing the genetic programmes at the basis of cooperative tumourigenesis, using basic and translational experimental models.

Potential topics include, but are not limited to, the following:

  • Intrinsic tumour suppression
  • Cancer initiation migration, invasion, and metastasis
  • Cancer metabolism
  • Tumour–stroma interactions
  • Cancer-related cell death
  • Organotypic models of cancer
  • Cell polarity and cell division in cancer
  • Cancer stem cells
  • Drug discovery

Dr. Helena Elizabeth Richardson
Dr. Daniela Grifoni
Dr. Julia B. Cordero
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Single-cell organisms in cancer research
  • Cold-blooded cancer models
  • Human tissue models
  • Organoids, Xenopatients, Germline and somatic GEMMS, Spontaneous tumour models

Related Special Issue

Published Papers (10 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

4 pages, 183 KiB  
Editorial
Basic and Translational Models of Cooperative Oncogenesis
by Helena E. Richardson, Julia B. Cordero and Daniela Grifoni
Int. J. Mol. Sci. 2020, 21(16), 5919; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21165919 - 18 Aug 2020
Cited by 4 | Viewed by 2237
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)

Research

Jump to: Editorial, Review

21 pages, 10591 KiB  
Article
Rounding up the Usual Suspects: Assessing Yorkie, AP-1, and Stat Coactivation in Tumorigenesis
by Fisun Hamaratoglu and Mardelle Atkins
Int. J. Mol. Sci. 2020, 21(13), 4580; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21134580 - 27 Jun 2020
Cited by 9 | Viewed by 3186
Abstract
Can hyperactivation of a few key signaling effectors be the underlying reason for the majority of epithelial cancers despite different driver mutations? Here, to address this question, we use the Drosophila model, which allows analysis of gene expression from tumors with known initiating [...] Read more.
Can hyperactivation of a few key signaling effectors be the underlying reason for the majority of epithelial cancers despite different driver mutations? Here, to address this question, we use the Drosophila model, which allows analysis of gene expression from tumors with known initiating mutations. Furthermore, its simplified signaling pathways have numerous well characterized targets we can use as pathway readouts. In Drosophila tumor models, changes in the activities of three pathways, Jun N-terminal Kinase (JNK), Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), and Hippo, mediated by AP-1 factors, Stat92E, and Yorkie, are reported frequently. We hypothesized this may indicate that these three pathways are commonly deregulated in tumors. To assess this, we mined the available transcriptomic data and evaluated the activity levels of eight pathways in various tumor models. Indeed, at least two out of our three suspects contribute to tumor development in all Drosophila cancer models assessed, despite different initiating mutations or tissues of origin. Surprisingly, we found that Notch signaling is also globally activated in all models examined. We propose that these four pathways, JNK, JAK/STAT, Hippo, and Notch, are paid special attention and assayed for systematically in existing and newly developed models. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

16 pages, 12029 KiB  
Article
The Splicing Factor SF2 Is Critical for Hyperproliferation and Survival in a TORC1-Dependent Model of Early Tumorigenesis in Drosophila
by Malgorzata Maria Parniewska and Hugo Stocker
Int. J. Mol. Sci. 2020, 21(12), 4465; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21124465 - 24 Jun 2020
Cited by 3 | Viewed by 2720
Abstract
The Target of Rapamycin complex 1 (TORC1) is an evolutionarily conserved kinase complex coordinating cellular growth with nutritional conditions and growth factor signaling, and its activity is elevated in many cancer types. The use of TORC1 inhibitors as anticancer drugs is, however, limited [...] Read more.
The Target of Rapamycin complex 1 (TORC1) is an evolutionarily conserved kinase complex coordinating cellular growth with nutritional conditions and growth factor signaling, and its activity is elevated in many cancer types. The use of TORC1 inhibitors as anticancer drugs is, however, limited by unwanted side-effects and development of resistance. We therefore attempted to identify limiting modulators or downstream effectors of TORC1 that could serve as therapeutic targets. Drosophila epithelial tissues that lack the tumor suppressor Pten hyperproliferate upon nutrient restriction in a TORC1-dependent manner. We probed candidates of the TORC1 signaling network for factors limiting the overgrowth of Pten mutant tissues. The serine/arginine-rich splicing factor 2 (SF2) was identified as the most limiting factor: SF2 knockdown drives Pten mutant cells into apoptosis, while not affecting control tissue. SF2 acts downstream of or in parallel to TORC1 but is not required for the activation of the TORC1 target S6K. Transcriptomics analysis revealed transcripts with alternatively used exons regulated by SF2 in the tumor context, including p53. SF2 may therefore represent a highly specific therapeutic target for tumors with hyperactive TORC1 signaling. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

16 pages, 3987 KiB  
Article
The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype
by Philipp Mayer, Alica Linnebacher, Hannah Glennemeier-Marke, Nicole Marnet, Frank Bergmann, Thilo Hackert, Miriam Klauss, Tanja Poth and Matthias M. Gaida
Int. J. Mol. Sci. 2020, 21(1), 346; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21010346 - 05 Jan 2020
Cited by 11 | Viewed by 3583
Abstract
Diffusion-weighted magnetic resonance imaging (DW-MRI) is a diagnostic tool that is increasingly used for the detection and characterization of focal masses in the abdomen, among these, pancreatic ductal adenocarcinoma (PDAC). DW-MRI reflects the microarchitecture of the tissue, and changes in diffusion, which are [...] Read more.
Diffusion-weighted magnetic resonance imaging (DW-MRI) is a diagnostic tool that is increasingly used for the detection and characterization of focal masses in the abdomen, among these, pancreatic ductal adenocarcinoma (PDAC). DW-MRI reflects the microarchitecture of the tissue, and changes in diffusion, which are reflected by changes in the apparent diffusion coefficient (ADC), are mainly attributed to variations in cellular density, glandular formation, and fibrosis. When analyzing the T cell infiltrates, we found an association of a tumor-promoting subpopulation, characterized by the expression of interleukin (IL) 21 and IL26, with high ADC values. Moreover, the presence of IL21+ and IL26+ positive T cells was associated with poor prognosis. Pancreatic cancers—but not healthy pancreatic tissue—expressed receptors for IL21 and IL26, a finding that could be confirmed in pancreatic cell lines. The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins. Moreover, in vitro data showed an increased colony formation of tumor cells. In summary, our data showed an association of IL21+ and IL26+ immune cell infiltration, increased ADC, and aggressive tumor disease, most likely due to the activation of the key cancer signaling pathways ERK1/2 and STAT3 and formation of tumor colonies. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

22 pages, 6822 KiB  
Article
Genetic Programs Driving Oncogenic Transformation: Lessons from In Vitro Models
by Eros Di Giorgio, Harikrishnareddy Paluvai, Raffaella Picco and Claudio Brancolini
Int. J. Mol. Sci. 2019, 20(24), 6283; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20246283 - 12 Dec 2019
Cited by 6 | Viewed by 2918
Abstract
Cancer complexity relies on the intracellular pleiotropy of oncogenes/tumor suppressors and in the strong interplay between tumors and micro- and macro-environments. Here we followed a reductionist approach, by analyzing the transcriptional adaptations induced by three oncogenes (RAS, MYC, and HDAC4 [...] Read more.
Cancer complexity relies on the intracellular pleiotropy of oncogenes/tumor suppressors and in the strong interplay between tumors and micro- and macro-environments. Here we followed a reductionist approach, by analyzing the transcriptional adaptations induced by three oncogenes (RAS, MYC, and HDAC4) in an isogenic transformation process. Common pathways, in place of common genes became dysregulated. From our analysis it emerges that, during the process of transformation, tumor cells cultured in vitro prime some signaling pathways suitable for coping with the blood supply restriction, metabolic adaptations, infiltration of immune cells, and for acquiring the morphological plasticity needed during the metastatic phase. Finally, we identified two signatures of genes commonly regulated by the three oncogenes that successfully predict the outcome of patients affected by different cancer types. These results emphasize that, in spite of the heterogeneous mutational burden among different cancers and even within the same tumor, some common hubs do exist. Their location, at the intersection of the various signaling pathways, makes a therapeutic approach exploitable. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Graphical abstract

Review

Jump to: Editorial, Research

14 pages, 1134 KiB  
Review
Strategies for Functional Interrogation of Big Cancer Data Using Drosophila Cancer Models
by Erdem Bangi
Int. J. Mol. Sci. 2020, 21(11), 3754; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21113754 - 26 May 2020
Cited by 4 | Viewed by 2416
Abstract
Rapid development of high throughput genome analysis technologies accompanied by significant reduction in costs has led to the accumulation of an incredible amount of data during the last decade. The emergence of big data has had a particularly significant impact in biomedical research [...] Read more.
Rapid development of high throughput genome analysis technologies accompanied by significant reduction in costs has led to the accumulation of an incredible amount of data during the last decade. The emergence of big data has had a particularly significant impact in biomedical research by providing unprecedented, systems-level access to many disease states including cancer, and has created promising opportunities as well as new challenges. Arguably, the most significant challenge cancer research currently faces is finding effective ways to use big data to improve our understanding of molecular mechanisms underlying tumorigenesis and developing effective new therapies. Functional exploration of these datasets and testing predictions from computational approaches using experimental models to interrogate their biological relevance is a key step towards achieving this goal. Given the daunting scale and complexity of the big data available, experimental systems like Drosophila that allow large-scale functional studies and complex genetic manipulations in a rapid, cost-effective manner will be of particular importance for this purpose. Findings from these large-scale exploratory functional studies can then be used to formulate more specific hypotheses to be explored in mammalian models. Here, I will discuss several strategies for functional exploration of big cancer data using Drosophila cancer models. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

12 pages, 1830 KiB  
Review
The Case of the Scribble Polarity Module in Asymmetric Neuroblast Division in Development and Tumorigenesis
by Ana Carmena
Int. J. Mol. Sci. 2020, 21(8), 2865; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21082865 - 20 Apr 2020
Cited by 2 | Viewed by 2832
Abstract
The Scribble polarity module is composed by Scribble (Scrib), Discs large 1 (Dlg1) and Lethal (2) giant larvae (L(2)gl), a group of highly conserved neoplastic tumor suppressor genes (TSGs) from flies to humans. Even though the Scribble module has been profusely studied in [...] Read more.
The Scribble polarity module is composed by Scribble (Scrib), Discs large 1 (Dlg1) and Lethal (2) giant larvae (L(2)gl), a group of highly conserved neoplastic tumor suppressor genes (TSGs) from flies to humans. Even though the Scribble module has been profusely studied in epithelial cell polarity, the number of tissues and processes in which it is involved is increasingly growing. Here we discuss the role of the Scribble module in the asymmetric division of Drosophila neuroblasts (NBs), as well as the underlying mechanisms by which those TSGs act in this process. Finally, we also describe what we know about the consequences of mutating these genes in impairing the process of asymmetric NB division and promoting tumor-like overgrowth. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

15 pages, 1397 KiB  
Review
Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer
by Stefano Sechi, Anna Frappaolo, Angela Karimpour-Ghahnavieh, Roberto Piergentili and Maria Grazia Giansanti
Int. J. Mol. Sci. 2020, 21(3), 933; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21030933 - 31 Jan 2020
Cited by 50 | Viewed by 5383
Abstract
Golgi phosphoprotein 3 (GOLPH3), a Phosphatidylinositol 4-Phosphate [PI(4)P] effector at the Golgi, is required for Golgi ribbon structure maintenance, vesicle trafficking and Golgi glycosylation. GOLPH3 has been validated as an oncoprotein through combining integrative genomics with clinopathological and functional analyses. It is frequently [...] Read more.
Golgi phosphoprotein 3 (GOLPH3), a Phosphatidylinositol 4-Phosphate [PI(4)P] effector at the Golgi, is required for Golgi ribbon structure maintenance, vesicle trafficking and Golgi glycosylation. GOLPH3 has been validated as an oncoprotein through combining integrative genomics with clinopathological and functional analyses. It is frequently amplified in several solid tumor types including melanoma, lung cancer, breast cancer, glioma, and colorectal cancer. Overexpression of GOLPH3 correlates with poor prognosis in multiple tumor types including 52% of breast cancers and 41% to 53% of glioblastoma. Roles of GOLPH3 in tumorigenesis may correlate with several cellular activities including: (i) regulating Golgi-to-plasma membrane trafficking and contributing to malignant secretory phenotypes; (ii) controlling the internalization and recycling of key signaling molecules or increasing the glycosylation of cancer relevant glycoproteins; and (iii) influencing the DNA damage response and maintenance of genomic stability. Here we summarize current knowledge on the oncogenic pathways involving GOLPH3 in human cancer, GOLPH3 influence on tumor metabolism and surrounding stroma, and its possible role in tumor metastasis formation. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

15 pages, 1216 KiB  
Review
Cytonemes, Their Formation, Regulation, and Roles in Signaling and Communication in Tumorigenesis
by Sergio Casas-Tintó and Marta Portela
Int. J. Mol. Sci. 2019, 20(22), 5641; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20225641 - 11 Nov 2019
Cited by 19 | Viewed by 4375
Abstract
Increasing evidence during the past two decades shows that cells interconnect and communicate through cytonemes. These cytoskeleton-driven extensions of specialized membrane territories are involved in cell–cell signaling in development, patterning, and differentiation, but also in the maintenance of adult tissue homeostasis, tissue regeneration, [...] Read more.
Increasing evidence during the past two decades shows that cells interconnect and communicate through cytonemes. These cytoskeleton-driven extensions of specialized membrane territories are involved in cell–cell signaling in development, patterning, and differentiation, but also in the maintenance of adult tissue homeostasis, tissue regeneration, and cancer. Brain tumor cells in glioblastoma extend ultralong membrane protrusions (named tumor microtubes, TMs), which contribute to invasion, proliferation, radioresistance, and tumor progression. Here we review the mechanisms underlying cytoneme formation, regulation, and their roles in cell signaling and communication in epithelial cells and other cell types. Furthermore, we discuss the recent discovery of glial cytonemes in the Drosophila glial cells that alter Wingless (Wg)/Frizzled (Fz) signaling between glia and neurons. Research on cytoneme formation, maintenance, and cell signaling mechanisms will help to better understand not only physiological developmental processes and tissue homeostasis but also cancer progression. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

15 pages, 1439 KiB  
Review
Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
by David L. Newman and Stephen L. Gregory
Int. J. Mol. Sci. 2019, 20(18), 4611; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20184611 - 18 Sep 2019
Cited by 12 | Viewed by 3880
Abstract
Alterations from the normal set of chromosomes are extremely common as cells progress toward tumourigenesis. Similarly, we expect to see disruption of normal cellular metabolism, particularly in the use of glucose. In this review, we discuss the connections between these two processes: how [...] Read more.
Alterations from the normal set of chromosomes are extremely common as cells progress toward tumourigenesis. Similarly, we expect to see disruption of normal cellular metabolism, particularly in the use of glucose. In this review, we discuss the connections between these two processes: how chromosomal aberrations lead to metabolic disruption, and vice versa. Both processes typically result in the production of elevated levels of reactive oxygen species, so we particularly focus on their role in mediating oncogenic changes. Full article
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
Show Figures

Figure 1

Back to TopTop